Evaluation of the efficacy of Simparica Trio® in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs

Evaluation of the efficacy of Simparica Trio® in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs

Abstract Background Babesia canis is a clinically relevant vector-borne pathogen in dogs, and its presence is expanding. The efficacy of Simparica Trio® (Zoetis) in the prevention of B. canis transmission was evaluated at the minimum recommended label dose of 1.2 mg/kg sarolaner, 24 µg/kg moxidectin...

Full description

Bibliographic Details
Main Authors: Stasia Borowski, Alta Viljoen, Lina D’Hanis, Sean Mahabir, Thomas Geurden
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Parasites & Vectors
Subjects:
Dogs
Dermacentor reticulatus
Babesia canis
Babesiosis
Transmission
Efficacy
Online Access:https://doi.org/10.1186/s13071-023-06115-2

Similar Items

Similar Items